225 related articles for article (PubMed ID: 34348617)
21. Nanoparticles and cancer therapy: Perspectives for application of nanoparticles in the treatment of cancers.
Aghebati-Maleki A; Dolati S; Ahmadi M; Baghbanzhadeh A; Asadi M; Fotouhi A; Yousefi M; Aghebati-Maleki L
J Cell Physiol; 2020 Mar; 235(3):1962-1972. PubMed ID: 31441032
[TBL] [Abstract][Full Text] [Related]
22. Nanomedicine: a new frontier in cancer therapeutics.
Lee PY; Wong KK
Curr Drug Deliv; 2011 May; 8(3):245-53. PubMed ID: 21291378
[TBL] [Abstract][Full Text] [Related]
23. Advances in nanomedicine for cancer starvation therapy.
Yu S; Chen Z; Zeng X; Chen X; Gu Z
Theranostics; 2019; 9(26):8026-8047. PubMed ID: 31754379
[TBL] [Abstract][Full Text] [Related]
24. Nanotherapeutics for Alzheimer's Disease with Preclinical Evaluation and Clinical Trials: Challenges, Promises and Limitations.
Bukhari SNA
Curr Drug Deliv; 2022; 19(1):17-31. PubMed ID: 34514990
[TBL] [Abstract][Full Text] [Related]
25. Nanotherapeutics in oral and parenteral drug delivery: Key learnings and future outlooks as we think small.
Tyagi P; Subramony JA
J Control Release; 2018 Feb; 272():159-168. PubMed ID: 29355619
[TBL] [Abstract][Full Text] [Related]
26. Critical quality attributes in the development of therapeutic nanomedicines toward clinical translation.
Taha MS; Padmakumar S; Singh A; Amiji MM
Drug Deliv Transl Res; 2020 Jun; 10(3):766-790. PubMed ID: 32170656
[TBL] [Abstract][Full Text] [Related]
27. Dendrimers toward Translational Nanotherapeutics: Concise Key Step Analysis.
Mignani S; Shi X; Rodrigues J; Roy R; Muñoz-Fernández Á; Ceña V; Majoral JP
Bioconjug Chem; 2020 Sep; 31(9):2060-2071. PubMed ID: 32786368
[TBL] [Abstract][Full Text] [Related]
28. Therapeutic nanoparticles for drug delivery in cancer.
Cho K; Wang X; Nie S; Chen ZG; Shin DM
Clin Cancer Res; 2008 Mar; 14(5):1310-6. PubMed ID: 18316549
[TBL] [Abstract][Full Text] [Related]
29. Magnetic nanoparticles for cancer theranostics: Advances and prospects.
Li X; Li W; Wang M; Liao Z
J Control Release; 2021 Jul; 335():437-448. PubMed ID: 34081996
[TBL] [Abstract][Full Text] [Related]
30. Nanotherapeutics: An insight into healthcare and multi-dimensional applications in medical sector of the modern world.
Prasad M; Lambe UP; Brar B; Shah I; J M; Ranjan K; Rao R; Kumar S; Mahant S; Khurana SK; Iqbal HMN; Dhama K; Misri J; Prasad G
Biomed Pharmacother; 2018 Jan; 97():1521-1537. PubMed ID: 29793315
[TBL] [Abstract][Full Text] [Related]
31. Contribution of biopharmaceutics and pharmacokinetics to improve drug therapy.
Domínguez-Gil A
Eur J Drug Metab Pharmacokinet; 1993; 18(1):1-5. PubMed ID: 8335032
[TBL] [Abstract][Full Text] [Related]
32. Clinical developments in nanotechnology for cancer therapy.
Heidel JD; Davis ME
Pharm Res; 2011 Feb; 28(2):187-99. PubMed ID: 20549313
[TBL] [Abstract][Full Text] [Related]
33. Development of multifunctional nanoparticles for targeted drug delivery and noninvasive imaging of therapeutic effect.
Sajja HK; East MP; Mao H; Wang YA; Nie S; Yang L
Curr Drug Discov Technol; 2009 Mar; 6(1):43-51. PubMed ID: 19275541
[TBL] [Abstract][Full Text] [Related]
34. Nanomedicines: Redefining traditional medicine.
Lu W; Yao J; Zhu X; Qi Y
Biomed Pharmacother; 2021 Feb; 134():111103. PubMed ID: 33338747
[TBL] [Abstract][Full Text] [Related]
35. Influence of nanomedicine mechanical properties on tumor targeting delivery.
Li Z; Xiao C; Yong T; Li Z; Gan L; Yang X
Chem Soc Rev; 2020 Apr; 49(8):2273-2290. PubMed ID: 32215407
[TBL] [Abstract][Full Text] [Related]
36. Nanomedicines for developing cancer nanotherapeutics: from benchtop to bedside and beyond.
Iqbal J; Abbasi BA; Ahmad R; Mahmood T; Ali B; Khalil AT; Kanwal S; Shah SA; Alam MM; Badshah H; Munir A
Appl Microbiol Biotechnol; 2018 Nov; 102(22):9449-9470. PubMed ID: 30219952
[TBL] [Abstract][Full Text] [Related]
37. Special Section on Nanotherapeutics in Cancer Research-Editorial.
Towner RA; Ahmed M
J Pharmacol Exp Ther; 2024 Jun; 390(1):29. PubMed ID: 38906563
[No Abstract] [Full Text] [Related]
38. Surface-Engineered Cancer Nanomedicine: Rational Design and Recent Progress.
Ahmad J; Ameeduzzafar ; Ahmad MZ; Akhter H
Curr Pharm Des; 2020; 26(11):1181-1190. PubMed ID: 32056517
[TBL] [Abstract][Full Text] [Related]
39. Nanomedicine in veterinary oncology.
Lin TY; Rodriguez CO; Li Y
Vet J; 2015 Aug; 205(2):189-97. PubMed ID: 25862394
[TBL] [Abstract][Full Text] [Related]
40. New Strategies in Cancer Nanomedicine.
Tong R; Kohane DS
Annu Rev Pharmacol Toxicol; 2016; 56():41-57. PubMed ID: 26514197
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
